Ochs H R, Greenblatt D J, Verburg-Ochs B, Abernethy D R, Knüchel M
Pharmacology. 1984;28(4):188-95. doi: 10.1159/000137961.
Factors influencing hepatic oxidation of antipyrine and conjugation of acetaminophen were evaluated in volunteers who received 1.0 g of antipyrine intravenously and on a different occasion a 650 mg intravenous dose of acetaminophen. In study one, subjects received both drugs in the control state and at another time during coadministration of isoniazid (INH), 180 mg daily. In control versus INH conditions, mean clearance of antipyrine was reduced from 0.67 to 0.60 ml/min/kg as was clearance of acetaminophen from 4.97 to 4.23 ml/min/kg, but these differences were not statistically significant. In study two, females on low-dose estrogen oral contraceptives (OC) and drug-free controls matched for age received both drugs. Compared to controls, OC users had reduced total clearance of antipyrine (0.71 vs. 0.50 ml/min/kg; p less than 0.005) and prolonged antipyrine t1/2 (9.6 vs. 13.3 h; p less than 0.005). For acetaminophen, however, OC users had higher clearance (5.2 vs. 6.1 ml/min/kg) and shorter t1/2 (2.2 vs. 1.9 h) although differences did not attain statistical significance. Clearance of antipyrine and acetaminophen across both studies was not statistically significantly correlated within individuals (r = 0.22). The capacities for drug oxidation and conjugation appear to be controlled by different mechanisms.
在静脉注射1.0g安替比林且在另一个不同场合静脉注射650mg对乙酰氨基酚的志愿者中,评估了影响安替比林肝氧化和对乙酰氨基酚结合的因素。在研究一中,受试者在对照状态下以及在每日服用180mg异烟肼(INH)的联合给药期间的另一个时间点接受这两种药物。在对照与INH条件下,安替比林的平均清除率从0.67降至0.60ml/min/kg,对乙酰氨基酚的清除率从4.97降至4.23ml/min/kg,但这些差异无统计学意义。在研究二中,服用低剂量雌激素口服避孕药(OC)的女性和年龄匹配的未服药对照者接受这两种药物。与对照者相比,服用OC者的安替比林总清除率降低(0.71对0.50ml/min/kg;p<0.005),安替比林t1/2延长(9.6对13.3小时;p<0.005)。然而,对于对乙酰氨基酚,服用OC者的清除率较高(5.2对6.1ml/min/kg),t1/2较短(2.2对1.9小时),尽管差异未达到统计学意义。在两项研究中,个体内安替比林和对乙酰氨基酚的清除率无统计学显著相关性(r = 0.22)。药物氧化和结合的能力似乎受不同机制控制。